ArticlePharmacoepidemiology and drug safety2017
Guidance to reinforce the credibility of health care database studies and ensure their appropriate impact.
Article in Pharmacoepidemiology and drug safety, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Transparency in the secondary use of health data: assessing the status quo of guidance and best practices.Royal Society open science · 2025Article
- With big data comes big responsibility: Strategies for utilizing aggregated, standardized, de-identified electronic health record data for research.Clinical and translational science · 2025Article
- Perspective review: Will generative AI make common data models obsolete in future analyses of distributed data networks?Therapeutic advances in drug safety · 2025Review
- Editorial: Traditional and innovative approaches for signal detection.Frontiers in drug safety and regulation · 2024Article
- Exploring prior diseases associated with incident late-onset Alzheimer's disease dementia.PloS one · 2020Article
- Data Science for Child Health.The Journal of pediatrics · 2019Review
- Observational research on sodium glucose co-transporter-2 inhibitors: A real breakthrough?Diabetes, obesity & metabolism · 2018Review
- The hope, hype and reality of Big Data for pharmacovigilance.Therapeutic advances in drug safety · 2018Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
28913965What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.